Literature DB >> 29726118

Gold Nanoparticles in Radiotherapy and Recent Progress in Nanobrachytherapy.

Myriam Laprise-Pelletier1,2,3, Teresa Simão1,2,3, Marc-André Fortin1,2,3.   

Abstract

Over the last few decades, gold nanoparticles (GNPs) have emerged as "radiosensitizers" in oncology. Radiosensitizers are additives that can enhance the effects of radiation on biological tissues treated with radiotherapy. The interaction of photons with GNPs leads to the emission of low-energy and short-range secondary electrons, which in turn increase the dose deposited in tissues. In this context, GNPs are the subject of intensive theoretical and experimental studies aiming at optimizing the parameters leading to greater dose enhancement and highest therapeutic effect. This review describes the main mechanisms occurring between photons and GNPs that lead to dose enhancement. The outcome of theoretical simulations of the interactions between GNPs and photons is presented. Finally, the findings of the most recent in vivo studies about interactions between GNPs and photon sources (e.g., external beams, brachytherapy sources, and molecules labeled with radioisotopes) are described. The advantages and challenges inherent to each of these approaches are discussed. Future directions, providing new guidelines for the successful translation of GNPs into clinical applications, are also highlighted.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  brachytherapy; gold nanoparticles; radioactive nanoparticles; radiotherapy

Mesh:

Substances:

Year:  2018        PMID: 29726118     DOI: 10.1002/adhm.201701460

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  17 in total

1.  Biodegradable Gold Nanoclusters with Improved Excretion Due to pH-Triggered Hydrophobic-to-Hydrophilic Transition.

Authors:  Elizabeth M Higbee-Dempsey; Ahmad Amirshaghaghi; Matthew J Case; Mathilde Bouché; Johoon Kim; David P Cormode; Andrew Tsourkas
Journal:  J Am Chem Soc       Date:  2020-04-21       Impact factor: 15.419

2.  Silver telluride nanoparticles as biocompatible and enhanced contrast agents for X-ray imaging: an in vivo breast cancer screening study.

Authors:  Lenitza M Nieves; Jessica C Hsu; Kristen C Lau; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2021-01-08       Impact factor: 7.790

Review 3.  Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.

Authors:  Yingbo Li; Jie Yang; Xilin Sun
Journal:  Front Chem       Date:  2021-04-22       Impact factor: 5.221

Review 4.  Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient.

Authors:  Sébastien Penninckx; Anne-Catherine Heuskin; Carine Michiels; Stéphane Lucas
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

5.  Antiproliferative and Antitumour Effect of Nongenotoxic Silver Nanoparticles on Melanoma Models.

Authors:  Lucía M Valenzuela-Salas; Nayeli G Girón-Vázquez; Juan C García-Ramos; Olivia Torres-Bugarín; Claudia Gómez; Alexey Pestryakov; Luis J Villarreal-Gómez; Yanis Toledano-Magaña; Nina Bogdanchikova
Journal:  Oxid Med Cell Longev       Date:  2019-07-25       Impact factor: 6.543

Review 6.  Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.

Authors:  Yao Chen; Juan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Int J Nanomedicine       Date:  2020-11-24

7.  Excretable, ultrasmall hexagonal NaGdF4:Yb50% nanoparticles for bimodal imaging and radiosensitization.

Authors:  Jossana A Damasco; Tymish Y Ohulchanskyy; Supriya Mahajan; Guanying Chen; Ajay Singh; Hilliard L Kutscher; Haoyuan Huang; Steven G Turowski; Joseph A Spernyak; Anurag K Singh; Jonathan F Lovell; Mukund Seshadri; Paras N Prasad
Journal:  Cancer Nanotechnol       Date:  2021-02-05

8.  Application of Carbon Ion and Its Sensitizing Agent in Cancer Therapy: A Systematic Review.

Authors:  Xiaolin Wang; Xiaojun Chen; Guangfei Li; Xiao Han; Tianxin Gao; Weifeng Liu; Xiaoying Tang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

9.  A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225.

Authors:  Evangelia-Alexandra Salvanou; Dimitris Stellas; Charalampos Tsoukalas; Barbara Mavroidi; Maria Paravatou-Petsotas; Nikolaos Kalogeropoulos; Stavros Xanthopoulos; Franck Denat; Gautier Laurent; Rana Bazzi; Stephane Roux; Penelope Bouziotis
Journal:  Pharmaceutics       Date:  2020-02-21       Impact factor: 6.321

Review 10.  Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine.

Authors:  Jossana A Damasco; Saisree Ravi; Joy D Perez; Daniel E Hagaman; Marites P Melancon
Journal:  Nanomaterials (Basel)       Date:  2020-11-02       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.